1. Home
  2. PCOR vs INSM Comparison

PCOR vs INSM Comparison

Compare PCOR & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCOR
  • INSM
  • Stock Information
  • Founded
  • PCOR 2003
  • INSM 1988
  • Country
  • PCOR United States
  • INSM United States
  • Employees
  • PCOR N/A
  • INSM N/A
  • Industry
  • PCOR Computer Software: Prepackaged Software
  • INSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • PCOR Technology
  • INSM Health Care
  • Exchange
  • PCOR Nasdaq
  • INSM Nasdaq
  • Market Cap
  • PCOR 10.6B
  • INSM 12.5B
  • IPO Year
  • PCOR 2021
  • INSM 2000
  • Fundamental
  • Price
  • PCOR $76.67
  • INSM $73.15
  • Analyst Decision
  • PCOR Buy
  • INSM Strong Buy
  • Analyst Count
  • PCOR 17
  • INSM 16
  • Target Price
  • PCOR $78.29
  • INSM $84.29
  • AVG Volume (30 Days)
  • PCOR 2.3M
  • INSM 1.7M
  • Earning Date
  • PCOR 10-30-2024
  • INSM 10-31-2024
  • Dividend Yield
  • PCOR N/A
  • INSM N/A
  • EPS Growth
  • PCOR N/A
  • INSM N/A
  • EPS
  • PCOR N/A
  • INSM N/A
  • Revenue
  • PCOR $1,109,701,000.00
  • INSM $342,958,000.00
  • Revenue This Year
  • PCOR $23.16
  • INSM $18.96
  • Revenue Next Year
  • PCOR $11.28
  • INSM $41.96
  • P/E Ratio
  • PCOR N/A
  • INSM N/A
  • Revenue Growth
  • PCOR 24.40
  • INSM 22.13
  • 52 Week Low
  • PCOR $49.46
  • INSM $21.92
  • 52 Week High
  • PCOR $83.35
  • INSM $80.53
  • Technical
  • Relative Strength Index (RSI)
  • PCOR 73.86
  • INSM 53.81
  • Support Level
  • PCOR $68.02
  • INSM $70.94
  • Resistance Level
  • PCOR $74.11
  • INSM $74.32
  • Average True Range (ATR)
  • PCOR 2.54
  • INSM 3.01
  • MACD
  • PCOR 0.35
  • INSM 0.45
  • Stochastic Oscillator
  • PCOR 86.91
  • INSM 85.11

About PCOR Procore Technologies Inc.

Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.

About INSM Insmed Incorporated

Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.

Share on Social Networks: